Annual Cash & Cash Equivalents
$26.35 M
-$10.79 M-29.05%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual cash & cash equivalents is $26.35 million, with the most recent change of -$10.79 million (-29.05%) on December 31, 2023.
- During the last 3 years, COCP annual cash & cash equivalents has fallen by -$6.66 million (-20.17%).
- COCP annual cash & cash equivalents is now -55.11% below its all-time high of $58.70 million, reached on December 31, 2021.
Performance
COCP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$13.02 M
-$5.12 M-28.24%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly cash and cash equivalents is $13.02 million, with the most recent change of -$5.12 million (-28.24%) on September 30, 2024.
- Over the past year, COCP quarterly cash and cash equivalents has dropped by -$16.72 million (-56.22%).
- COCP quarterly cash and cash equivalents is now -80.59% below its all-time high of $67.06 million, reached on June 30, 2021.
Performance
COCP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
COCP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.1% | -56.2% |
| 3 y3 years | -20.2% | -65.0% |
| 5 y5 years | +867.8% | -65.0% |
COCP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.1% | at low | -77.8% | at low |
| 5 y | 5-year | -55.1% | +255.3% | -80.6% | +75.5% |
| alltime | all time | -55.1% | >+9999.0% | -80.6% | >+9999.0% |
Cocrystal Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.02 M(-28.2%) |
| Jun 2024 | - | $18.14 M(-16.9%) |
| Mar 2024 | - | $21.84 M(-17.1%) |
| Dec 2023 | $26.35 M(-29.1%) | $26.35 M(-11.4%) |
| Sep 2023 | - | $29.74 M(-8.3%) |
| Jun 2023 | - | $32.42 M(-4.6%) |
| Mar 2023 | - | $33.98 M(-8.5%) |
| Dec 2022 | $37.14 M(-36.7%) | $37.14 M(-11.7%) |
| Sep 2022 | - | $42.06 M(-17.6%) |
| Jun 2022 | - | $51.03 M(-6.9%) |
| Mar 2022 | - | $54.79 M(-6.7%) |
| Dec 2021 | $58.70 M(+77.8%) | $58.70 M(-4.8%) |
| Sep 2021 | - | $61.64 M(-8.1%) |
| Jun 2021 | - | $67.06 M(+101.5%) |
| Mar 2021 | - | $33.28 M(+0.8%) |
| Dec 2020 | $33.01 M(+345.0%) | $33.01 M(+3.9%) |
| Sep 2020 | - | $31.78 M(+64.5%) |
| Jun 2020 | - | $19.32 M(-10.9%) |
| Mar 2020 | - | $21.69 M(+192.3%) |
| Dec 2019 | $7.42 M(+172.4%) | $7.42 M(+23.8%) |
| Sep 2019 | - | $5.99 M(-19.8%) |
| Jun 2019 | - | $7.47 M(-12.8%) |
| Mar 2019 | - | $8.57 M(+214.8%) |
| Dec 2018 | $2.72 M(+264.0%) | $2.72 M(-41.9%) |
| Sep 2018 | - | $4.68 M(-31.5%) |
| Jun 2018 | - | $6.84 M(+447.7%) |
| Mar 2018 | - | $1.25 M(+67.0%) |
| Dec 2017 | $748.00 K(-79.3%) | $748.00 K(-44.4%) |
| Sep 2017 | - | $1.34 M(-61.0%) |
| Jun 2017 | - | $3.45 M(+121.9%) |
| Mar 2017 | - | $1.55 M(-56.9%) |
| Dec 2016 | $3.60 M | $3.60 M(-39.0%) |
| Sep 2016 | - | $5.91 M(+17.6%) |
| Jun 2016 | - | $5.02 M(-51.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $10.24 M(+10.4%) |
| Dec 2015 | $9.28 M(+133.7%) | $9.28 M(-25.3%) |
| Sep 2015 | - | $12.41 M(-21.3%) |
| Jun 2015 | - | $15.78 M(+10.7%) |
| Mar 2015 | - | $14.26 M(+259.1%) |
| Dec 2014 | $3.97 M(+283.9%) | $3.97 M(+32.1%) |
| Sep 2014 | - | $3.01 M(-26.2%) |
| Jun 2014 | - | $4.07 M(+56.8%) |
| Mar 2014 | - | $2.60 M(+151.4%) |
| Dec 2013 | $1.03 M(>+9900.0%) | $1.03 M(+95.1%) |
| Sep 2013 | - | $529.90 K(+49.5%) |
| Jun 2013 | - | $354.50 K(+284.9%) |
| Mar 2013 | - | $92.10 K(+1037.0%) |
| Dec 2012 | $8100.00(-98.1%) | $8100.00(-90.2%) |
| Sep 2012 | - | $82.60 K(-52.6%) |
| Jun 2012 | - | $174.20 K(+126.5%) |
| Mar 2012 | - | $76.90 K(-81.5%) |
| Dec 2011 | $416.30 K(+65.5%) | $416.30 K(-46.7%) |
| Sep 2011 | - | $781.70 K(-57.5%) |
| Jun 2011 | - | $1.84 M(-13.3%) |
| Mar 2011 | - | $2.12 M(+743.9%) |
| Dec 2010 | $251.50 K(+483.5%) | $251.50 K(+926.5%) |
| Sep 2010 | - | $24.50 K(-9.6%) |
| Jun 2010 | - | $27.10 K(-25.8%) |
| Mar 2010 | - | $36.50 K(-15.3%) |
| Dec 2009 | $43.10 K(-42.2%) | $43.10 K(-6.7%) |
| Sep 2009 | - | $46.20 K(-5.1%) |
| Jun 2009 | - | $48.70 K(-21.6%) |
| Mar 2009 | - | $62.10 K(-16.8%) |
| Dec 2008 | $74.60 K(-32.1%) | $74.60 K(-6.0%) |
| Sep 2008 | - | $79.40 K(-6.7%) |
| Jun 2008 | - | $85.10 K(-9.9%) |
| Mar 2008 | - | $94.50 K(-13.9%) |
| Dec 2007 | $109.80 K | $109.80 K |
FAQ
- What is Cocrystal Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cocrystal Pharma?
- What is Cocrystal Pharma annual cash & cash equivalents year-on-year change?
- What is Cocrystal Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly cash and cash equivalents year-on-year change?
What is Cocrystal Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of COCP is $26.35 M
What is the all time high annual cash & cash equivalents for Cocrystal Pharma?
Cocrystal Pharma all-time high annual cash & cash equivalents is $58.70 M
What is Cocrystal Pharma annual cash & cash equivalents year-on-year change?
Over the past year, COCP annual cash & cash equivalents has changed by -$10.79 M (-29.05%)
What is Cocrystal Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of COCP is $13.02 M
What is the all time high quarterly cash and cash equivalents for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly cash and cash equivalents is $67.06 M
What is Cocrystal Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, COCP quarterly cash and cash equivalents has changed by -$16.72 M (-56.22%)